A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD). (Q48406974)
Jump to navigation
Jump to search
scientific article published on 15 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD). |
scientific article published on 15 December 2014 |
Statements
1 reference
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD). (English)
1 reference
1 reference
Alan Thomas
1 reference
Ly-Mee Yu
1 reference
Claire Merritt
1 reference
Christopher Davison
1 reference
Narenda Sharma
1 reference
Zunera Khan
1 reference
Byron Creese
1 reference
Paul Loughlin
1 reference
Carol Bannister
1 reference
Soe Nyunt Win
1 reference
MAIN-AD investigators
1 reference
15 December 2014
1 reference
16
1 reference
4
1 reference
316-322
1 reference
Identifiers
1 reference